SEC Form 4 · accession 0001645627-18-000010
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President
Period of report
Feb 14, 2018
Accepted (ET)
Feb 16, 2018 · 2:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 14, 2018 | P | 1,000 | $0.0409 | A | 24,811,189 | D | |
| Common Stock | Feb 14, 2018 | P | 1,000 | $0.04 | A | 24,812,189 | D | |
| Common Stock | Feb 14, 2018 | P | 1,000 | $0.04 | A | 24,813,189 | D | |
| Common Stock | Feb 14, 2018 | P | 1,000 | $0.04 | A | 24,814,189 | D | |
| Common Stock | Feb 15, 2018 | P | 1,000 | $0.042 | A | 24,815,189 | D | |
| Common Stock | Feb 15, 2018 | P | 1,000 | $0.044 | A | 24,816,189 | D | |
| Common Stock | Feb 15, 2018 | P | 1,000 | $0.044 | A | 24,817,189 | D | |
| Common Stock | Feb 15, 2018 | P | 1,000 | $0.052 | A | 24,818,189 | D | |
| Common Stock | Feb 15, 2018 | P | 1,000 | $0.051 | A | 24,819,189 | D | |
| Common Stock | Feb 15, 2018 | P | 1,000 | $0.0519 | A | 24,820,189 | D | |
| Common Stock | Feb 15, 2018 | P | 1,000 | $0.052 | A | 24,821,189 | D | |
| Common Stock | Feb 15, 2018 | P | 1,000 | $0.051 | A | 24,822,189 | D | |
| Common Stock | Feb 15, 2018 | P | 1,000 | $0.052 | A | 24,823,189 | D |
Table II — derivative securities
No Table II lines on this filing.